熱門資訊> 正文

Tenax Therapeutics任命新首席财务官

2026-04-22 19:18

Tenax Therapeutics (TENX) appointed Thomas R. Staab II as CFo, effective May 11, 2026, replacing interim CFO Thomas McGauley.
Staab brings more than 25 years of financial leadership experience in the healthcare sector. He most recently served as CFO and secretary at LENSAR.
Tenax (TENX) also announced inducement equity awards tied to the appointment, including 10,000 restricted stock units and options to purchase 450,000 common shares

More on Tenax Therapeutics

Tenax Therapeutics: A Binary Bet With Heavy Downside Likely
Tenax Therapeutics: Some Future Potential
Tenax wins bullish view at Cantor ahead of pivotal readout
Seeking Alpha’s Quant Rating on Tenax Therapeutics
Historical earnings data for Tenax Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。